Rucha Patil: Our ”Factor VIII Inhibitor Point-of-Care Diagnostic” Is Successfully Transferred at Science-Tech
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, reposted from ICMR-NIRBID on LinkedIn:
”Reposting with immense pride and gratitude
Truly delighted to see our ‘Factor VIII Inhibitor Point-of-Care Diagnostic’ successfully transferred at Science–Tech’ on National Technology Day 2026.
Grateful to my wonderful team – Sharda Shanbhag, Sweta Kaskar, and Moni Singh – and honoured that this milestone was achieved in the presence of Hon’ble Minister Dr Jitendra Singh .
Proud to see this innovation licensed to Meril Pvt Ltd – bringing us a step closer to accessible and affordable hemophilia diagnostics.”
Quoting ICMR-National Institute for Research on Blood and Immune Disorders, (ICMR-NIRBID)‘s post:
”ICMR–NIRBID is especially proud to highlight the successful technology transfer of its novel ‘Factor VIII Inhibitor Point-of-Care Diagnostic’, developed by Rucha Patil, Sharda Shanbhag, Sweta Kaskar, and Moni Singh, at the national programme Science–Tech’ held on the occasion of National Technology Day 2026 at BRIC–National Institute of Immunology, in the presence of Jitendra Singh, Hon’ble Minister of State (Independent Charge), Ministry of Science and Technology and Ministry of Earth Sciences; MoS, PMO; Ministry of Personnel, Public Grievances and Pensions; Department of Atomic Energy; and Department of Space, Government of India.
This innovation has been licensed to Meril Life Sciences, marking a significant advancement toward enhancing accessible and timely diagnostics for hemophilia care.
The novel FVIII inhibitor POCT is a low-cost, point-of-care lateral flow assay based on gold nanoparticle technology, enabling rapid detection of FVIII inhibitors at approximately one-twentieth the cost of the gold-standard assay, while remaining unaffected by non-factor therapies.”
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 18:43Hugh Nguyen: Honored to Accept the Friend of Singapore Red Cross Award
-
Sep 24, 2026, 18:42Titilope Fasipe: Proud to Support American Society of Hematology’s SCD Initiative
-
Sep 24, 2026, 18:34Ifeanyichukwu Ifechidere: Why Coagulation Samples Can Be “Too Valuable to Throw Away”?
-
Sep 24, 2026, 18:33Aswin K. Mohan: When a Superpower Hears the Call for Blood
-
Sep 24, 2026, 18:31Mercy Lung’aho: Anemia Is Not Only An Iron Problem
-
Sep 24, 2026, 18:29Nick Hanson: Before a Dementia Diagnosis Check Vitamin B12
-
Sep 24, 2026, 18:28Rachel McBryan: Nearly One in Five Older Canadians Has Low Vitamin B12
-
Sep 24, 2026, 18:27Kemal Karaagac: Early DOAC Initiation After Acute Ischaemic Stroke in Atrial Fibrillation
-
Sep 24, 2026, 18:26Mohammed A. AlOmar: What Characterizes Young Stroke in the UAE?